Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Five Prime Thera (FPRX)

Five Prime Thera (FPRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,769,736
  • Shares Outstanding, K 46,572
  • Annual Sales, $ 13,180 K
  • Annual Income, $ -84,330 K
  • 60-Month Beta 4.63
  • Price/Sales 134.26
  • Price/Cash Flow N/A
  • Price/Book 5.45
Trade FPRX with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -2.30
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/06/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00%
  • Historical Volatility 5.68%
  • IV Percentile 0%
  • IV Rank N/A
  • IV High 0.00% on N/A
  • IV Low 0.00% on N/A
  • Put/Call Vol Ratio N/A
  • Today's Volume N/A
  • Volume Avg (30-Day) N/A
  • Put/Call OI Ratio N/A
  • Today's Open Interest N/A
  • Open Int (30-Day) N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.54
  • Number of Estimates 2
  • High Estimate -0.35
  • Low Estimate -0.72
  • Prior Year -0.57
  • Growth Rate Est. (year over year) +5.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
37.60 +1.06%
on 04/05/21
38.01 -0.03%
on 04/15/21
+0.14 (+0.37%)
since 03/15/21
3-Month
13.63 +178.80%
on 01/21/21
38.90 -2.31%
on 03/09/21
+23.78 (+167.23%)
since 01/15/21
52-Week
2.61 +1,355.94%
on 04/16/20
38.90 -2.31%
on 03/09/21
+35.19 (+1,252.31%)
since 04/15/20

Most Recent Stories

More News
Amgen Successfully Completes Acquisition Of Five Prime Therapeutics

, /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it has successfully completed its previously announced tender offer to purchase all outstanding shares of common stock of Five Prime Therapeutics...

AMGN : 213.61 (-0.67%)
FPRX : 38.00 (+0.03%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates STAY, CUB, AEGN, FPRX; Shareholders are Encouraged to Contact the Firm

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

STAY : 20.46 (unch)
CUB : 75.00 (+0.32%)
AEGN : 29.99 (-0.03%)
FPRX : 38.00 (+0.03%)
Lifshitz Law Firm, P.C. Announces Investigation of ATH, WIFI, BMTC, WSFS, DSSI, INSW, FPRX, FI, HWCC, and RMBL

, /PRNewswire/ --

ATH : 69.79 (+1.88%)
WIFI : 13.99 (+0.07%)
BMTC : 42.25 (+1.54%)
WSFS : 47.12 (+1.75%)
DSSI : 9.69 (+2.00%)
INSW : 17.55 (+0.69%)
FPRX : 38.00 (+0.03%)
FI : 2.89 (-0.34%)
HGV : 49.31 (+1.82%)
HWCC : 5.30 (+0.19%)
RMBL : 35.90 (+3.73%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds HWCC, FI, SVBI, and FRPX Shareholders About Its Ongoing Investigations

, /PRNewswire/ --

HWCC : 5.30 (+0.19%)
FI : 2.89 (-0.34%)
SVBI : 12.35 (+1.15%)
FPRX : 38.00 (+0.03%)
Halper Sadeh LLP Investigates the Following Mergers - TPCO, STAY, KSU, CUB, AEGN, FPRX; Shareholders Are Encouraged to Contact the Firm

, /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

TPCO : 17.26 (+0.41%)
STAY : 20.46 (unch)
KSU : 272.43 (+0.27%)
CUB : 75.00 (+0.32%)
AEGN : 29.99 (-0.03%)
FPRX : 38.00 (+0.03%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds FI, SVBI, FRPX, and VKIN Shareholders About Its Ongoing Investigations

,, /PRNewswire/ -- 

FI : 2.89 (-0.34%)
SVBI : 12.35 (+1.15%)
FPRX : 38.00 (+0.03%)
VKIN : 1.3300 (+6.40%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates JCS, MIK, CRHM, FPRX; Shareholders Are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / March 23, 2021 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

JCS : 9.73 (-3.66%)
MIK : 21.97 (-0.14%)
CRHM : 3.99 (unch)
FPRX : 38.00 (+0.03%)
Lifshitz Law Firm, P.C. Announces Investigation of FPRX, NBLX, PAND, and SHBI

NEW YORK, NY / ACCESSWIRE / March 21, 2021 / Five Prime Therapeutics, Inc. (NASDAQ:FPRX)

AMGN : 213.61 (-0.67%)
FPRX : 38.00 (+0.03%)
NBLX : 15.21 (-0.59%)
PAND : 60.05 (+0.22%)
SHBI : 17.52 (+1.98%)
BREAKING NEWS ALERT: Halper Sadeh LLP Investigates CTB, FFG, PAND, SVBI, FPRX; Shareholders are Encouraged to Contact the Firm

, /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

CTB : 60.17 (-0.05%)
FFG : 60.99 (+0.03%)
PAND : 60.05 (+0.22%)
SVBI : 12.35 (+1.15%)
FPRX : 38.00 (+0.03%)
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigations of FRTA, AEGN, FPRX, and MIK Buyouts

Rigrodsky Law, P.A. announces that it is investigating:

FRTA : 23.51 (+0.04%)
AEGN : 29.99 (-0.03%)
FPRX : 38.00 (+0.03%)
MIK : 21.97 (-0.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Five Prime Therapeutics, Inc. is a biotechnology company. The company focuses on the discovery and development of protein therapeutics that blocks cancer and inflammatory disease processes. It operates primarily in the United States and Canada. Five Prime Therapeutics, Inc. is based in San Francisco,...

See More

Key Turning Points

3rd Resistance Point 38.08
2nd Resistance Point 38.05
1st Resistance Point 38.02
Last Price 38.00
1st Support Level 37.96
2nd Support Level 37.93
3rd Support Level 37.90

See More

52-Week High 38.90
Last Price 38.00
Fibonacci 61.8% 25.04
Fibonacci 50% 20.76
Fibonacci 38.2% 16.47
52-Week Low 2.61

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar